NBSE

NeuBase Therapeutics, Inc. Common Stock

Delisted

NBSE was delisted on the 10th of May, 2024.

15 hedge funds and large institutions have $677K invested in NeuBase Therapeutics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
-9
Holders Change %
-37.5%
% of All Funds
0.33%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
3
Reduced
2
Closed
11
Calls
Puts
Net Calls
Net Calls Change